Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Kinstrie

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Hematologic Malignancy Reports|December 25, 2012
Targeting chronic myeloid leukemia stem cellsRoss Kinstrie, Mhairi Copland
Pharmaceutical Patent Analyst|June 2, 2015
Novel drug therapies in myeloid leukemiaGillian A Horne, Ross Kinstrie, Mhairi Copland
Frontiers in Cell and Developmental Biology|August 6, 2019
Epigenetic Reprogramming and Emerging Epigenetic Therapies in CMLJane Bugler, Ross Kinstrie, Mary T Scott, et al.
The Biochemical Journal|May 5, 2006
dDYRK2 and Minibrain interact with the chromatin remodelling factors SNR1 and TRXRoss Kinstrie, Pamela A Lochhead, Gary Sibbet, et al.
Molecular Cell|December 26, 2006
A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylationPamela A Lochhead, Ross Kinstrie, Gary Sibbet, et al.
Science Signaling|March 4, 2010
Characterization of a domain that transiently converts class 2 DYRKs into intramolecular tyrosine kinasesRoss Kinstrie, Nathan Luebbering, Diego Miranda-Saavedra, et al.
The Biochemical Journal|June 6, 2003
dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in DrosophilaPamela A Lochhead, Gary Sibbet, Ross Kinstrie, et al.
Blood Advances|January 4, 2018
Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemiaRoss Kinstrie, Dimitris Karamitros, Nicolas Goardon, et al.
Blood|April 1, 2011
Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in miceChris A H Hansell, Chris Schiering, Ross Kinstrie, et al.
Scientific Reports|May 10, 2016
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemiaDavid A Irvine, Bin Zhang, Ross Kinstrie, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Hematologic Malignancy Reports|December 25, 2012
Targeting chronic myeloid leukemia stem cellsRoss Kinstrie, Mhairi Copland
Pharmaceutical Patent Analyst|June 2, 2015
Novel drug therapies in myeloid leukemiaGillian A Horne, Ross Kinstrie, Mhairi Copland
Frontiers in Cell and Developmental Biology|August 6, 2019
Epigenetic Reprogramming and Emerging Epigenetic Therapies in CMLJane Bugler, Ross Kinstrie, Mary T Scott, et al.
The Biochemical Journal|May 5, 2006
dDYRK2 and Minibrain interact with the chromatin remodelling factors SNR1 and TRXRoss Kinstrie, Pamela A Lochhead, Gary Sibbet, et al.
Molecular Cell|December 26, 2006
A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylationPamela A Lochhead, Ross Kinstrie, Gary Sibbet, et al.
Science Signaling|March 4, 2010
Characterization of a domain that transiently converts class 2 DYRKs into intramolecular tyrosine kinasesRoss Kinstrie, Nathan Luebbering, Diego Miranda-Saavedra, et al.
The Biochemical Journal|June 6, 2003
dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in DrosophilaPamela A Lochhead, Gary Sibbet, Ross Kinstrie, et al.
Blood Advances|January 4, 2018
Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemiaRoss Kinstrie, Dimitris Karamitros, Nicolas Goardon, et al.
Blood|April 1, 2011
Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in miceChris A H Hansell, Chris Schiering, Ross Kinstrie, et al.
Scientific Reports|May 10, 2016
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemiaDavid A Irvine, Bin Zhang, Ross Kinstrie, et al.
Pageof 2